Pentoxifylline (PTX) selectively potentiates cyclosporine (CsA)-mediated suppression of cell-mediated lymphocytotoxicity. Median-effect analysis for the drug dose reductions in PTX and CsA combination treatment.
Khabar
K S
KS
Laboratories of Interferon and Cytokine Research, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Dzimiri
M
M
Parhar
R S
RS
Siddiqui
S
S
Einspenner
M
M
Al-Humaidan
A
A
Al-Sediary
S T
ST
D016572:Cyclosporine / Q000494:pharmacology*; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D004357:Drug Synergism; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008214:Lymphocytes / Q000187:drug effects* / Q000276:immunology; D010431:Pentoxifylline / Q000494:pharmacology*; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*
D007166:Immunosuppressive Agents; D010726:Phosphodiesterase Inhibitors; D016572:Cyclosporine; D010431:Pentoxifylline